Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) EPS (diluted)
Chemed Corporation's EPS (diluted) for fiscal 2025 was $18.34, down 7.79% from $19.89 in fiscal 2024. Over the twelve months to 30 September 2026 it was $20.90. Over the past ten years it has ranged from $5.86 (fiscal 2017) to $19.89 (fiscal 2024); the current reading is higher than 82% of that period. Chemed Corporation ranks 5th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $18.34 | (7.79%) |
| FY2024 | $19.89 | 10.93% |
| FY2023 | $17.93 | 8.47% |
| FY2022 | $16.53 | (1.90%) |
| FY2021 | $16.85 | (13.50%) |
| FY2020 | $19.48 | 46.36% |
| FY2019 | $13.31 | 8.83% |
| FY2018 | $12.23 | 108.70% |
| FY2017 | $5.86 | (9.57%) |
| FY2016 | $6.48 | 2.37% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $5.45 | 6.24% |
| Jun 2026 | $5.13 | 5.99% |
| Mar 2026 | $4.84 | (11.68%) |
| Dec 2025 | $5.48 | 22.87% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| UHS Universal Health Services, Inc. compare | $23.99 |
| CHE Chemed Corporation | $20.90 |
| DVA DaVita Inc. compare | $13.58 |
| ENSG The Ensign Group, Inc. compare | $6.72 |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $1.87 |
| PACS PACS Group, Inc. compare | $1.77 |
| CON Concentra Group Holdings Parent, Inc. compare | $1.69 |
| OPCH Option Care Health, Inc. compare | $1.39 |
| LFST LifeStance Health Group, Inc. compare | $0.19 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CHE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement